The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Sep. 28, 2015
Applicant:

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Markus H. Frank, Cambridge, MA (US);

Natasha Y. Frank, Cambridge, MA (US);

Assignee:
Attorney:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); G01N 33/574 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); C07K 16/40 (2006.01); C12N 15/113 (2010.01); C12Q 1/6886 (2018.01); A61K 47/55 (2017.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 38/1709 (2013.01); A61K 39/3955 (2013.01); A61K 47/55 (2017.08); C07K 16/40 (2013.01); C12N 15/1138 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5743 (2013.01); G01N 33/57415 (2013.01); G01N 33/57419 (2013.01); G01N 33/57423 (2013.01); G01N 33/57434 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/51 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C12N 2310/122 (2013.01); C12N 2310/14 (2013.01); C12N 2310/3513 (2013.01); C12Q 2600/158 (2013.01);
Abstract

The present invention relates in part to the discovery of genes that are deregulated in cancer stem cells (e.g., melanoma stem cells). In some aspects, methods for treating individuals having melanoma are provided; the methods involve modulating (e.g., inducing, inhibiting, etc.) the activity of the cancer stem cell associated genes. In other aspects, cell surface genes that are upregulated in melanoma stem cells are targeted for the selective isolation, detection, and killing of cancer stem cells in melanoma. Other aspects of the invention relate to reagents, arrays, compositions, and kits that are useful for diagnosing and treating melanoma.


Find Patent Forward Citations

Loading…